CPRX (CPRX)

Financial Metrics & Valuation Analysis

Enterprise Valuation (TTM)

Enterprise Value$3.10B
EV / Sales5.20
EV / EBITDA9.27
EV / Operating Cash Flow14.90
EV / Free Cash Flow14.90

Return Metrics (TTM)

Return on Equity (ROE)23.65%
Return on Assets (ROA)19.29%
Return on Invested Capital (ROIC)19.67%
Return on Capital Employed (ROCE)26.36%

Yield Metrics

Earnings Yield5.75%
Free Cash Flow Yield5.40%

Balance Sheet Strength

Net Debt / EBITDA-2.25
Current Ratio7.10
Working Capital$807.99M
Tangible Asset Value$890.73M
Net Current Asset Value$805.48M

Working Capital Efficiency

Days Sales Outstanding80.28
Days Payables Outstanding24.74
Operating Cycle (Days)201.11
Cash Conversion Cycle176.37

Capital Allocation

CapEx / Revenue0.01%
CapEx / Operating Cash Flow0.04%
R&D / Revenue1.92%
SG&A / Revenue32.86%

Fiscal Year 2025 Ratios

Audited annual results as of 2025-12-31

Margins

Gross Profit Margin85.19%
Operating Margin43.77%
Net Profit Margin36.39%

Solvency

Debt / Equity0.00
Quick Ratio5.82
Cash Ratio4.82

Per Share

Revenue / Share$4.82
FCF / Share$1.71
PE Ratio13.34